These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9849751)

  • 1. Tobacco smoking, alcohol, and special diet in drug trials: exclusion criteria or target of specific investigations?
    Fuhr U
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):604-6. PubMed ID: 9849751
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral administration of drugs. Influence of diet, alcohol and smoking habits].
    Fernández E; Guerrero S
    Odontol Chil; 1988 Apr; 36(1):67-72. PubMed ID: 3275265
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of ethanol and smoking on the pharmacokinetics and pharmacodynamics of psychotropic medications.
    Shoaf SE; Linnoila M
    Psychopharmacol Bull; 1991; 27(4):577-94. PubMed ID: 1813903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alcohol, tobacco and drugs].
    Burrus O
    Rev Infirm; 1985 Jul; 35(13):40-3. PubMed ID: 3849864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug effects in elderly subjects: from the pharmacologic target to the risk-benefit. Round Table #5 of the 16th National Clinical Pharmacology Workshop].
    Lassale C; Piette F; Jolliet P
    Therapie; 2001; 56(4):363-7. PubMed ID: 11677853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of drugs with alcohol.
    Barry M
    Practitioner; 1991 Mar; 235(1500):270-2. PubMed ID: 1852712
    [No Abstract]   [Full Text] [Related]  

  • 7. Amprenavir (Agenerase).
    Simmons P
    Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking, the missing drug interaction in clinical trials: ignoring the obvious.
    Gritz ER; Dresler C; Sarna L
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2287-93. PubMed ID: 16214906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical drug trials. 1: The 4 phases of clinical trials].
    Gleiter CH; Bieck PR
    Fortschr Med; 1991 Feb; 109(5):136-7. PubMed ID: 2045036
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98.
    Humphreys K; Weingardt KR; Horst D; Joshi AA; Finney JW
    Addiction; 2005 Sep; 100(9):1249-57. PubMed ID: 16128714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological issues in clinical trials of drug and behavior therapies.
    Holroyd KA; Powers SW; Andrasik F
    Headache; 2005 May; 45(5):487-92. PubMed ID: 15953265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
    Ericson M; Löf E; Stomberg R; Söderpalm B
    J Pharmacol Exp Ther; 2009 Apr; 329(1):225-30. PubMed ID: 19126781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. So many studies, too few subjects: establishing functional relevance of genetic polymorphisms on pharmacokinetics.
    Williams JA; Johnson K; Paulauskis J; Cook J
    J Clin Pharmacol; 2006 Mar; 46(3):258-64. PubMed ID: 16490801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and cultural considerations in alcohol treatment clinical trials: issues in clinical research related to race and ethnicity.
    Taylor RE
    Alcohol Clin Exp Res; 2003 Aug; 27(8):1345-8. PubMed ID: 12966336
    [No Abstract]   [Full Text] [Related]  

  • 16. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoking cessation during treatment of alcohol dependence in drug and alcohol rehabilitation centres--a review].
    Metz K; Kröger C; Bühringer G
    Gesundheitswesen; 2005 Jul; 67(7):461-7. PubMed ID: 16103969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
    Evans M; Lewis GM
    Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking.
    Lee CH; Wu DC; Lee JM; Wu IC; Goan YG; Kao EL; Huang HL; Chan TF; Chou SH; Chou YP; Lee CY; Chen PS; Ho CK; He J; Wu MT
    Eur J Cancer; 2007 May; 43(7):1188-99. PubMed ID: 17383866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.